ALAlign Technology ALGN NASDAQ · Healthcare · United States
$155.17 -2.82% -$4.51
- Market cap
- $11.3B
- Enterprise value
- $10.3B
- P/E
- 22.9x
- Forward P/E
- 13.9x
- PEG
- -
- P/S
- 2.7x
- P/FCF
- 18.7x
- EV/EBITDA
- 13.8x
- ROIC
- 10.3%
- Gross margin
- 67.6%
- Net margin
- 11.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.3x
- Beta
- 1.74
- Free float
- 94.2%
About the company
Align Technology (ALGN) is an American healthcare company specializing in the development and production of orthodontic and dental devices, particularly the Invisalign system. This innovative system of clear aligners is designed to provide an effective and aesthetically pleasing solution for teeth straightening. The company is known for its focus on technological innovations and digital dental technologies, enabling it to offer cutting-edge orthodontic solutions. Align Technology also invests in research and development to continually improve its products and expand its portfolio. Align Technology (ALGN) shares could be suitable for investors looking for opportunities in the medical technology sector with an emphasis on orthodontic innovations and aesthetic solutions.
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Hogan
Employees
20,290
Headquarters
Tempe
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue growth is slowing: 2.6% a year over the last 3 years against 10% over 5 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 12 USD is left as net profit.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $1.14B against $146.5M.
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It bought back its own shares for $465.9M in the last fiscal year, 4.1% of its market value.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
- What to watch: The price moves much more than the market (beta 1.74).
Statements
Every number